International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases.

Autor: Boycott KM; Children's Hospital Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada., Lau LP; IRDiRC Scientific Secretariat, Paris, France.; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, USA., Cutillo CM; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, USA., Austin CP; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, USA.
Jazyk: angličtina
Zdroj: EMBO molecular medicine [EMBO Mol Med] 2019 May; Vol. 11 (5).
DOI: 10.15252/emmm.201910486
Databáze: MEDLINE